HKD 70.0
(4.48%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 1.09 Billion CNY | -23.59% |
2022 | 1.43 Billion CNY | 9.06% |
2021 | 1.31 Billion CNY | -19.54% |
2020 | 1.63 Billion CNY | 203.54% |
2019 | 540.26 Million CNY | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 Q3 | 1.09 Billion CNY | 1.57% |
2023 Q2 | 1.08 Billion CNY | 0.0% |
2023 Q4 | 1.09 Billion CNY | 0.0% |
2023 Q1 | 1.08 Billion CNY | -24.77% |
2023 FY | 1.09 Billion CNY | -23.59% |
2022 Q4 | 1.43 Billion CNY | 0.0% |
2022 Q3 | 1.43 Billion CNY | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Natural Beauty Bio-Technology Limited | 308.05 Million HKD | -256.945% |
Innovative Pharmaceutical Biotech Limited | 1.06 Billion HKD | -3.386% |
China Overseas Nuoxin International Holdings Limited | 109.1 Million HKD | -907.873% |
Prosperous Future Holdings Limited | 177.1 Million HKD | -520.861% |
Huasheng International Holding Limited | 675.58 Million HKD | -62.763% |
Fourace Industries Group Holdings Limited | 61.8 Million HKD | -1679.144% |
Evergreen Products Group Limited | 786.46 Million HKD | -39.815% |
EC Healthcare | 2.97 Billion HKD | 62.98% |
Ming Fai International Holdings Limited | 772.01 Million HKD | -42.433% |
Blue Moon Group Holdings Limited | 1.61 Billion HKD | 32.033% |
SuperRobotics Holdings Limited | 172.27 Million HKD | -538.293% |
Takbo Group Holdings Limited | 42.84 Million HKD | -2466.221% |
Hyfusin Group Holdings Limited | 181.34 Million HKD | -506.348% |